These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22589540)

  • 1. Tyrosine kinase Btk is required for NK cell activation.
    Bao Y; Zheng J; Han C; Jin J; Han H; Liu Y; Lau YL; Tu W; Cao X
    J Biol Chem; 2012 Jul; 287(28):23769-78. PubMed ID: 22589540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
    Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
    J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta2 integrin CD11b attenuates polyinosinic:polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions.
    Zhang M; Han Y; Han C; Xu S; Bao Y; Chen Z; Gu Y; Xia D; Cao X
    Hepatology; 2009 Nov; 50(5):1606-16. PubMed ID: 19821527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia.
    Fiedler K; Sindrilaru A; Terszowski G; Kokai E; Feyerabend TB; Bullinger L; Rodewald HR; Brunner C
    Blood; 2011 Jan; 117(4):1329-39. PubMed ID: 21063022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
    Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
    J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes.
    Korbel DS; Newman KC; Almeida CR; Davis DM; Riley EM
    J Immunol; 2005 Dec; 175(11):7466-73. PubMed ID: 16301654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis.
    Dugan CM; Fullerton AM; Roth RA; Ganey PE
    Toxicol Sci; 2011 Apr; 120(2):507-18. PubMed ID: 21245496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).
    Sun R; Gao B
    Gastroenterology; 2004 Nov; 127(5):1525-39. PubMed ID: 15521020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B.
    Ratnam DT; Sievert W; Visvanathan K
    Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation.
    Liu J; Liu S; Xia M; Xu S; Wang C; Bao Y; Jiang M; Wu Y; Xu T; Cao X
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7814-9. PubMed ID: 23610400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia.
    Taneichi H; Kanegane H; Sira MM; Futatani T; Agematsu K; Sako M; Kaneko H; Kondo N; Kaisho T; Miyawaki T
    Clin Immunol; 2008 Feb; 126(2):148-54. PubMed ID: 18271077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of ascorbic acid impairs NK cell activity against ovarian cancer in a mouse model.
    Kim JE; Cho HS; Yang HS; Jung DJ; Hong SW; Hung CF; Lee WJ; Kim D
    Immunobiology; 2012 Sep; 217(9):873-81. PubMed ID: 22306178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential markers of NK-92 associated to cytotoxicity against K562 cells.
    Song X; Xu C; Wu X; Zhao X; Fan J; Meng S
    Biologicals; 2020 Nov; 68():46-53. PubMed ID: 32933840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-α-producing PDCA-1+ Siglec-H- B cells mediate innate immune defense by activating NK cells.
    Bao Y; Han Y; Chen Z; Xu S; Cao X
    Eur J Immunol; 2011 Mar; 41(3):657-68. PubMed ID: 21287550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
    Dons'koi BV; Chernyshov VP; Osypchuk DV
    J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharide from
    Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
    Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation.
    Ciaglia E; Pisanti S; Picardi P; Laezza C; Malfitano AM; D'Alessandro A; Gazzerro P; Vitale M; Carbone E; Bifulco M
    J Leukoc Biol; 2013 Dec; 94(6):1207-19. PubMed ID: 23847096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA.
    Perrot I; Deauvieau F; Massacrier C; Hughes N; Garrone P; Durand I; Demaria O; Viaud N; Gauthier L; Blery M; Bonnefoy-Berard N; Morel Y; Tschopp J; Alexopoulou L; Trinchieri G; Paturel C; Caux C
    J Immunol; 2010 Aug; 185(4):2080-8. PubMed ID: 20639488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.